Phibro Animal Health (NASDAQ:PAHC) Upgraded by StockNews.com to Strong-Buy Rating

Phibro Animal Health (NASDAQ:PAHC) was upgraded by analysts at StockNews.com from a “buy” rating to a “strong-buy” rating in a report issued on Tuesday.

A number of other equities research analysts also recently weighed in on the stock. JPMorgan Chase & Co. assumed coverage on shares of Phibro Animal Health in a research report on Tuesday, September 10th. They issued a “neutral” rating and a $22.00 price target for the company. Barclays boosted their target price on shares of Phibro Animal Health from $13.00 to $20.00 and gave the stock an “underweight” rating in a research note on Tuesday. Finally, Bank of America boosted their price objective on shares of Phibro Animal Health from $13.00 to $15.00 and gave the stock an “underperform” rating in a research note on Friday, August 30th. Three investment analysts have rated the stock with a sell rating, one has given a hold rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, Phibro Animal Health has an average rating of “Hold” and an average price target of $16.50.

Phibro Animal Health Trading Down 1.9 %

Phibro Animal Health stock traded down $0.49 during mid-day trading on Tuesday, hitting $25.06. 314,254 shares of the company’s stock were exchanged, compared to its average volume of 157,197. The company’s 50 day simple moving average is $22.46 and its 200-day simple moving average is $19.52. The firm has a market capitalization of $1.01 billion, a P/E ratio of 58.28, a PEG ratio of 0.58 and a beta of 0.51. The company has a quick ratio of 1.64, a current ratio of 3.23 and a debt-to-equity ratio of 1.81. Phibro Animal Health has a fifty-two week low of $9.40 and a fifty-two week high of $25.98.

Phibro Animal Health (NASDAQ:PAHC) last posted its quarterly earnings results on Wednesday, August 28th. The company reported $0.41 EPS for the quarter, topping analysts’ consensus estimates of $0.34 by $0.07. Phibro Animal Health had a return on equity of 21.59% and a net margin of 1.67%. The business had revenue of $273.16 million during the quarter, compared to analysts’ expectations of $262.44 million. On average, equities analysts anticipate that Phibro Animal Health will post 1.63 earnings per share for the current year.

Insiders Place Their Bets

In other Phibro Animal Health news, Director E Thomas Corcoran acquired 5,000 shares of the business’s stock in a transaction that occurred on Wednesday, September 4th. The stock was bought at an average cost of $20.02 per share, with a total value of $100,100.00. Following the acquisition, the director now owns 25,000 shares in the company, valued at approximately $500,500. This represents a 0.00 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is accessible through the SEC website. 50.07% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of PAHC. Brandes Investment Partners LP lifted its holdings in shares of Phibro Animal Health by 1.2% during the 2nd quarter. Brandes Investment Partners LP now owns 2,405,629 shares of the company’s stock worth $40,521,000 after acquiring an additional 29,071 shares during the last quarter. Dimensional Fund Advisors LP increased its position in shares of Phibro Animal Health by 5.7% during the second quarter. Dimensional Fund Advisors LP now owns 775,470 shares of the company’s stock valued at $13,005,000 after buying an additional 42,086 shares during the period. Acadian Asset Management LLC increased its position in shares of Phibro Animal Health by 6.3% during the second quarter. Acadian Asset Management LLC now owns 717,506 shares of the company’s stock valued at $12,027,000 after buying an additional 42,299 shares during the period. Dana Investment Advisors Inc. boosted its stake in Phibro Animal Health by 17.2% during the second quarter. Dana Investment Advisors Inc. now owns 513,926 shares of the company’s stock worth $8,619,000 after acquiring an additional 75,546 shares in the last quarter. Finally, American Century Companies Inc. boosted its stake in Phibro Animal Health by 119.6% during the second quarter. American Century Companies Inc. now owns 347,191 shares of the company’s stock worth $5,822,000 after acquiring an additional 189,068 shares in the last quarter. 99.34% of the stock is owned by institutional investors.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.